All Insights

Life Sciences and Healthcare

EU's 'flexible' pharma reforms likely to require fine-tuning to address uncertainties

The reduction of the regulatory data protection period and wholesale distribution changes raise some industry concern
Artificial intelligence

What risks need to be considered by a UK business using artificial intelligence?

An overview of the legal and regulatory risks arising from AI deployment published in our article in Compliance & Risk
Competition, antitrust and trade

Spain draws €194m line in Apple-Amazon brand protection and competition restriction ruling

Contractual terms at issue for competition regulator include 'brand gating' and competitor product ad restrictions
Intellectual property

Taking control: Navigating Russia’s brand seizures

Russia has assumed ownership of the Russian subsidiaries of Danone and Carlsberg, which can be analysed from two perspectives: investment
Knowledge Notes

Reviewing our UK business law predictions for 2023: how are we doing at the half-way point?

We examine how our predictions have turned out in practice, and what to watch out for as autumn draws nearer
Intellectual property

Destruction of Goods as a Corrective Measure Ordered by National Courts

Article 10(1) of Directive 2004/48/EC of the European Parliament and of the Council of 29 April 2004 on the enforcement
Unified Patent Court

UPC's former London Central Division competences to be reallocated between Paris, Munich and Milan

The provisional Paris-Munich competence split will continue until the new agreement comes into force in June 2024
Intellectual property

Changes to legal professional privilege and trade secret protection in Poland

An amendment to the Act on Competition and Consumer Protection (ACCP) entered into force on 20 May 2023. The main
Retail and Consumer

Supermarket clash underscores need for clarity from UK Supreme Court on trade mark bad faith

Bad faith claim succeeded in ongoing dispute but trade mark and copyright infringement and passing off still found

Life Sciences and Healthcare

Use of trade mark for food supplements does not amount to genuine use for pharma products

Food supplements are not considered as a sub-set of pharmaceutical products in class 5 for proving genuine trade mark use
Artificial intelligence

Generative AI: is its output protectable by intellectual property rights?

Creative AI engines can create new text, images, video and audio. Is there IP in this content and, if so